Sotera Health (SHC) Financials: History & Chart

Sotera Health Company(SHC)

Medical - Diagnostics & Research · Broadview Heights, OH

$18.22-0.33 (-1.77%)

Delayed quote: Oct 6, 2026, 3:45 PM EDT

About Sotera Health Company

Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.

Broadview Heights, OH

3,000 employees

soterahealth.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Alton E. Shader

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	1.22B	321.38M	280.05M	303.44M	311.31M	294.34M	254.52M	290.20M	285.47M
Cost of Goods Sold	550.69M	143.41M	136.01M	137.52M	133.75M	127.72M	119.09M	125.84M	127.44M
Gross Profit	665.48M	177.96M	144.04M	165.92M	177.56M	166.62M	135.43M	164.37M	158.02M
Gross Profit Margin	54.7%	55.4%	51.4%	54.7%	57.0%	56.6%	53.2%	56.6%	55.4%
Total Operating Expenses	224.75M	71.17M	57.40M	29.80M	66.38M	78.19M	78.39M	77.22M	77.52M
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	246.36M	68.16M	57.40M	57.51M	63.29M	68.89M	63.06M	61.84M	62.01M
Operating Income (EBIT)	440.73M	106.79M	86.64M	136.12M	111.18M	88.43M	57.04M	87.15M	80.51M
Operating Margin	36.2%	33.2%	30.9%	44.9%	35.7%	30.0%	22.4%	30.0%	28.2%
Income Before Tax (EBT)	264.10M	78.05M	42.61M	70.50M	72.94M	18.90M	-14.82M	44.96M	42.75M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	143.34M	34.41M	34.74M	35.05M	39.15M	40.65M	40.88M	40.96M	41.57M
Other Income/Expense	-176.63M	-28.74M	-44.03M	-65.62M	-38.24M	-69.53M	-71.87M	-42.18M	-37.75M
Net Income	163.48M	53.64M	26.59M	34.85M	48.40M	7.96M	-13.26M	12.32M	17.00M
Income Tax Expense	100.62M	24.41M	16.02M	35.65M	24.54M	10.94M	-1.56M	32.64M	25.76M
Net Profit Margin	13.4%	16.7%	9.5%	11.5%	15.5%	2.7%	-5.2%	4.2%	6.0%
EBITDA	572.68M	140.12M	118.13M	176.93M	137.51M	124.01M	97.85M	127.46M	123.57M
EBITDA Margin	47.1%	43.6%	42.2%	58.3%	44.2%	42.1%	38.4%	43.9%	43.3%
Depreciation & Amortization	131.95M	33.33M	31.49M	40.80M	26.33M	35.58M	40.80M	40.31M	43.06M
EPS Basic	0.57	0.19	0.09	0.12	0.17	0.03	-0.05	0.04	0.06
EPS Diluted	0.57	0.19	0.09	0.12	0.17	0.03	-0.05	0.04	0.06
Weighted Average Basic Shares	285.77M	285.77M	284.89M	283.96M	284.07M	283.93M	283.56M	282.78M	283.06M
Weighted Average Diluted Shares	288.15M	288.15M	287.62M	286.42M	286.75M	285.76M	283.56M	284.91M	285.56M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	1.16B	1.10B	1.05B	1.00B	931.48M	818.16M	778.33M	746.15M
Cost of Goods Sold	518.08M	498.15M	472.13M	446.68M	412.81M	374.59M	382.90M	388.90M
Gross Profit	645.53M	602.29M	577.16M	557.00M	518.67M	443.57M	395.43M	357.25M
Gross Profit Margin	55.5%	54.7%	55.0%	55.5%	55.7%	54.2%	50.8%	47.9%
Total Operating Expenses	252.76M	304.67M	300.47M	308.65M	261.94M	237.55M	211.83M	191.34M
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	252.76M	242.63M	236.67M	245.71M	198.16M	178.53M	147.48M	133.36M
Operating Income (EBIT)	392.77M	297.63M	276.69M	248.35M	256.73M	206.02M	183.60M	80.85M
Operating Margin	33.8%	27.0%	26.4%	24.7%	27.6%	25.2%	23.6%	10.8%
Income Before Tax (EBT)	147.51M	113.87M	106.03M	-243.11M	175.72M	-38.86M	-916K	24.22M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	155.72M	164.69M	142.88M	80.14M	74.19M	215.26M	157.73M	143.33M
Other Income/Expense	-245.27M	-183.75M	-170.66M	-491.46M	-81.02M	-244.88M	-184.51M	-56.63M
Net Income	77.95M	44.40M	51.38M	-233.57M	116.88M	-38.62M	-20.85M	-5.87M
Income Tax Expense	69.56M	69.48M	54.65M	-9.54M	58.59M	-1.37M	19.51M	30.10M
Net Profit Margin	6.7%	4.0%	4.9%	-23.3%	12.5%	-4.7%	-2.7%	-0.8%
EBITDA	531.80M	461.26M	434.62M	393.90M	407.63M	349.58M	330.32M	227.66M
EBITDA Margin	45.7%	41.9%	41.4%	39.2%	43.8%	42.7%	42.4%	30.5%
Depreciation & Amortization	139.03M	163.64M	157.93M	145.55M	150.90M	143.56M	146.72M	146.82M
EPS Basic	0.27	0.16	0.18	-0.83	0.41	-0.14	-0.07	-0.02
EPS Diluted	0.27	0.16	0.18	-0.83	0.41	-0.14	-0.07	-0.02
Weighted Average Basic Shares	283.96M	282.78M	281.01M	280.10M	279.23M	283.25M	284.42M	246.15M
Weighted Average Diluted Shares	286.42M	284.91M	283.22M	280.10M	279.38M	283.25M	284.42M	246.15M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.